The expression of Nrf2 in HCC tissue was suppressed by DPP4 inhibitor treatment [87], suggesting that Nrf2 downregulation resulted in the suppressed synthesis of purine nucleotides. Here, DPP4 is linked to hepatocellular carcinoma.